ARS Pharmaceuticals Inc. (SPRY)
undefined
undefined%
At close: undefined
12.05
1.13%
After-hours Dec 13, 2024, 07:09 PM EST

Balance Sheet (Annual)

Get detailed breakdowns of the balance-sheet with total debts, total investments, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18
Cash & Equivalents 70.97M 210.52M 60.06M 24.52M 9.98M 20.16M
Short-Term Investments 157.39M 63.86M - - - -
Long-Term Investments - - 64.78M 350.00K 550.00K 750.00K
Other Long-Term Assets 21.00K 2.96M -64.76M -348.00K - -
Receivables 795.00K - 1K 384.00K - -
Inventory - -1.01M -6.78M -2.61M - -
Other Current Assets 2.57M 2.31M 666.00K 1.48M 552.00K 618.00K
Total Current Assets 231.73M 277.70M 60.73M 26.38M 10.53M 20.78M
Property-Plant & Equipment 824.00K 774.00K 693.00K 23.00K 4.57M 6.02M
Goodwill & Intangibles 617.00K - - - - -
Total Long-Term Assets 1.46M 3.73M 716.00K 25.00K 5.12M 6.77M
Total Assets 233.19M 281.44M 61.45M 26.41M 15.65M 27.55M
Account Payables 759.00K 1.66M 1.79M 1.22M 3.52M 775.00K
Deferred Revenue - 283.00K 1.46M 3.52M - -
Short-Term Debt 474.00K 460.00K 3.62M 2.56M 12.30M 3.53M
Other Current Liabilities 1.15M 2.87M 1.32M 915.00K 2.11M 841.00K
Total Current Liabilities 2.39M 5.44M 8.19M 8.21M 17.93M 5.14M
Long-Term Debt 37.00K 251.00K 5.41M 7.46M 3.32M 4.21M
Other Long-Term Liabilities - - 76.12M 27.00K - -1
Total Long-Term Liabilities 37.00K 3.10M 84.53M 32.25M 3.32M 4.21M
Total Liabilities 2.43M 8.55M 92.72M 40.46M 21.25M 9.35M
Total Debt 274.00K 481.00K 9.03M 10.02M 15.62M 7.73M
Common Stock 10.00K 9.00K 257.00K 223.00K - -
Retained Earnings -131.30M -76.94M -42.26M -22.01M -63.79M -39.82M
Comprehensive Income 49.00K 407.00K -326.00K -21.23M - -
Shareholders Equity 230.76M 272.89M -31.27M -14.05M -5.60M 18.20M
Total Investments 157.39M 63.86M 64.78M 350.00K 550.00K 750.00K